Back to today’s briefing

Story perspectives

Rare Mutation Offers New Hope for ALS Treatment

4/9/2025

50 4

Summary

Story summary

A groundbreaking study in Nature Communications uncovers that the rare R119G mutation in the CREB3 protein significantly lowers the risk of amyotrophic lateral sclerosis (ALS) and slows its progression. Patients with this mutation enjoy nearly an extra year of life, prompting researchers to propose boosting CREB3 activity as a promising new treatment avenue for ALS.

1 of 1

Story summary

A groundbreaking study in Nature Communications uncovers that the rare R119G mutation in the CREB3 protein significantly lowers the risk of amyotrophic lateral sclerosis (ALS) and slows its progression. Patients with this mutation enjoy nearly an extra year of life, prompting researchers to propose boosting CREB3 activity as a promising new treatment avenue for ALS.